Radiosensitivity
(Redirected from Law of Bergonié and Tribondeau)
Radiosensitivity refers to the relative susceptibility of cells, tissues, organs or organisms to the harmful effect of radiation. It is a significant concept in radiobiology and radiation therapy.
Overview[edit | edit source]
Radiosensitivity is determined by a number of factors, including the rate of cell division, the type of tissue, and the stage of cell cycle. Cells that are rapidly dividing, such as cancer cells, are generally more radiosensitive than cells that are not. Similarly, tissues that have a high rate of cell turnover, such as the skin and the lining of the gastrointestinal tract, are more radiosensitive than tissues with a low rate of cell turnover, such as muscle and nerve tissue.
Factors affecting radiosensitivity[edit | edit source]
Several factors can affect the radiosensitivity of a cell or tissue. These include:
- Cell cycle: Cells are most radiosensitive in the late G2 and M phases of the cell cycle, and least radiosensitive in the late S phase.
- Oxygen effect: The presence of oxygen in a cell can increase its radiosensitivity, a phenomenon known as the oxygen effect.
- Repair capacity: Cells with a high capacity for DNA repair are less radiosensitive than cells with a low repair capacity.
- Genetic factors: Certain genetic conditions, such as Ataxia telangiectasia and Nijmegen breakage syndrome, are associated with increased radiosensitivity.
Radiosensitivity and cancer treatment[edit | edit source]
In the context of cancer treatment, radiosensitivity is a critical factor in the success of radiation therapy. Tumors that are highly radiosensitive, such as lymphomas and seminomas, can often be effectively treated with radiation. Conversely, tumors that are radioresistant, such as melanomas and sarcomas, are less likely to respond to radiation therapy.
See also[edit | edit source]
References[edit | edit source]
Radiosensitivity Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD